Grace Therapeutics, Inc. 8-K

What Happened
On June 18, 2026, Grace Therapeutics, Inc. (GRCE) filed a Form 8-K under Item 8.01 to announce that it updated its corporate presentation. The updated presentation is attached to the filing as Exhibit 99.1 and is dated June 17, 2026; the presentation is incorporated by reference into the Form 8-K.

Key Details

• Form 8-K filed: June 18, 2026 (Item 8.01 — Other Events).
• Exhibit included: 99.1 — Corporate Presentation, dated June 17, 2026 (incorporated by reference).
• The filing also includes the Inline XBRL cover page (Exhibit 104) as part of the submission.

Why It Matters
By filing the updated corporate presentation as an exhibit to an 8-K, Grace has made that presentation part of its public SEC record. Investors should review Exhibit 99.1 directly for any changes to the company's messaging, strategy, product pipeline or milestones; the 8-K itself does not summarize presentation contents. Monitoring the presentation and subsequent company communications can help investors stay current on any material business updates.